+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics Contract Development Market - Global Forecast 2026-2032- Product Image
Biologics Contract Development Market - Global Forecast 2026-2032- Product Image
New

Biologics Contract Development Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011399
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biologics contract development market is evolving rapidly, shaped by innovation, diverse technology platforms, and shifting commercial and regulatory dynamics. Senior executives seeking to evaluate strategic opportunities will benefit from a structured overview of forces steering this high-complexity global landscape.

Market Snapshot

The Biologics Contract Development Market grew from USD 8.17 billion in 2025 to USD 9.15 billion in 2026. It is expected to continue growing at a CAGR of 12.18%, reaching USD 18.29 billion by 2032. This robust performance highlights strong industry momentum as scientific innovation, manufacturing complexity, regulatory expectations, and partnership models redefine what biopharmaceutical sponsors require from contract development organizations.

Scope & Segmentation

  • Service Types: Clinical manufacturing (spanning Phase I–III), commercial-scale manufacturing, fill-finish operations, process development (including upstream and downstream optimization).
  • Molecule Modalities: Cell and gene therapies, monoclonal antibodies (including bispecifics and antibody-drug conjugates), recombinant proteins, vaccines (bacterial, mRNA, viral).
  • Therapeutic Focuses: Autoimmune disorders, cardiovascular diseases, infectious diseases (separating bacterial and viral targets), oncology (segmented into hematology and solid tumors).
  • Host Systems: Mammalian (CHO, NS0), microbial (E. coli, yeast) production platforms with distinct process and analytical requirements.
  • End Users: Biopharmaceutical companies, contract manufacturing organizations, and traditional pharmaceutical firms, each with unique partnership and commercialization goals.
  • Technology Choices: Continuous manufacturing, perfusion and single-pass systems, single-use/disposable platforms, stainless-steel equipment, advanced analytics, digital twins, and real-time process monitoring.
  • Regional Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific—each presenting varied regulatory, talent, and supply chain considerations.

Key Takeaways

  • Scientific advances in modalities such as cell therapies and monoclonal antibody engineering are expanding the specialized requirements for contract development services.
  • Adoption of digital technologies—including real-time monitoring, advanced analytics, and digital twins—is elevating process robustness and speeding troubleshooting, thereby reshaping sponsor-provider contracts and expectations.
  • Strategic partnerships between sponsors and service providers reflect a shift from transactional engagements to deeper collaborations, prioritized by flexibility and intellectual property protection.
  • The rise of platform-enabled service offerings allows providers to adapt validated processes across multiple programs, accelerating development while enhancing value for biopharma clients.
  • Regulatory agencies are moving toward harmonized pathways and faster reviews for innovative modalities, prompting earlier integration of regulatory alignment in process development plans.
  • Regional opportunity involves weighing proximity to major trial populations, regulatory alignment, and secure supply chains to inform site selection and sourcing strategies.

Tariff Impact

Tariff adjustments and evolving trade policies have direct consequences on raw material and equipment sourcing, landed costs, and supply continuity. Providers with diversified sourcing strategies and local inventory are better positioned to absorb these changes, while onshoring and contract renegotiation may be necessary for long-term resilience. This underscores the need for scenario planning, risk assessment, and strong collaboration across the global supply network.

Methodology & Data Sources

This analysis employs a robust mixed-method research approach. Primary data was collected via structured interviews with experts across development, manufacturing, regulatory, and procurement functions. Secondary research involved the systematic review of company disclosures, regulatory guidance, scientific literature, and industry reports. Triangulation ensured that segmentation and trends reflect validated consensus. Limitations were addressed through transparent disclosure of methods and by weighting primary insights for regional representation.

Why This Report Matters

  • Enables clear prioritization of investments in people, technologies, and platforms aligned to evolving biologics market needs.
  • Supports executive-level strategic planning through actionable guidance amidst complex regulation and rapid modality innovation.
  • Provides risk mitigation strategies for supply chain, tariff exposure, and partnership structure, strengthening operational and commercial resilience.

Conclusion

Success in biologics contract development depends on deliberate capability building, proactive regulatory engagement, and robust supply chain planning. Organizations leveraging technology and flexible partnership models will be best positioned for future growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biologics Contract Development Market, by Service Type
8.1. Clinical Manufacturing
8.1.1. Phase I
8.1.2. Phase II
8.1.3. Phase III
8.2. Commercial Manufacturing
8.3. Fill Finish
8.4. Process Development
8.4.1. Downstream Development
8.4.2. Upstream Development
9. Biologics Contract Development Market, by Molecule Type
9.1. Cell Gene Therapy
9.2. Monoclonal Antibodies
9.2.1. Bispecific
9.2.2. Conjugated
9.2.3. Naked
9.3. Recombinant Proteins
9.4. Vaccines
9.4.1. Bacterial
9.4.2. Mrna
9.4.3. Viral
10. Biologics Contract Development Market, by Therapeutic Area
10.1. Autoimmune Disorders
10.2. Cardiovascular
10.3. Infectious Diseases
10.3.1. Bacterial
10.3.2. Viral
10.4. Oncology
10.4.1. Hematology
10.4.2. Solid Tumors
11. Biologics Contract Development Market, by Host System
11.1. Mammalian
11.1.1. Cho Cells
11.1.2. Ns0 Cells
11.2. Microbial
11.3. Yeast
12. Biologics Contract Development Market, by Technology
12.1. Continuous Manufacturing
12.1.1. Perfusion
12.1.2. Single Pass
12.2. Single Use Systems
12.3. Stainless Steel Systems
13. Biologics Contract Development Market, by End User
13.1. Biopharmaceutical Companies
13.2. Contract Manufacturing Organizations
13.3. Pharmaceutical Companies
14. Biologics Contract Development Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Biologics Contract Development Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Biologics Contract Development Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Biologics Contract Development Market
18. China Biologics Contract Development Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie, Inc.
19.6. Abzena Ltd.
19.7. Aenova Holding GmbH
19.8. AGC Biologics GmbH
19.9. Avid Bioservices, Inc.
19.10. Binex Co. Limited
19.11. Boehringer Ingelheim International GmbH
19.12. Cambrex Corporation
19.13. Catalent, Inc.
19.14. Emergent BioSolutions, Inc.
19.15. Fujifilm Holdings Corporation
19.16. Icon PLC
19.17. JRS PHARMA GmbH & Co. KG
19.18. JSR Life Sciences, LLC
19.19. Lonza Group AG
19.20. Parexel International Corporation
19.21. ProBioGen AG
19.22. Recipharm AB
19.23. Rentschler Biopharma SE
19.24. Samsung Biologics
19.25. Takeda Pharmaceutical Company Limited
19.26. Thermo Fisher Scientific, Inc.
19.27. Toyobo Co., Ltd.
19.28. WuXi Biologics Inc.
List of Figures
FIGURE 1. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY FILL FINISH, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY FILL FINISH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY FILL FINISH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BISPECIFIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BISPECIFIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BISPECIFIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NAKED, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NAKED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NAKED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CHO CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CHO CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NS0 CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NS0 CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PERFUSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PERFUSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PERFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE PASS, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE PASS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE PASS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE USE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE USE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE USE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STAINLESS STEEL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STAINLESS STEEL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STAINLESS STEEL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 199. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 200. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 201. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 202. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 203. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 204. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 205. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 206. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 207. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 208. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 209. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 211. EUROPE BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 228. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 229. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 230. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 231. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 232. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 233. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 234. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 235. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 236. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 237. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 238. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 239. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 241. AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 258. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 260. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 261. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 262. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 263. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 264. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 265. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 266. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 267. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 268. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 269. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 270. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 271. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 272. ASEAN BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 273. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 274. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 275. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 276. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 277. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 278. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 279. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 280. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 281. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 282. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 283. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2032 (USD MILLION)
TABLE 284. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 285. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 286. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 287. GCC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TAB

Companies Mentioned

The key companies profiled in this Biologics Contract Development market report include:
  • AbbVie, Inc.
  • Abzena Ltd.
  • Aenova Holding GmbH
  • AGC Biologics GmbH
  • Avid Bioservices, Inc.
  • Binex Co. Limited
  • Boehringer Ingelheim International GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Emergent BioSolutions, Inc.
  • Fujifilm Holdings Corporation
  • Icon PLC
  • JRS PHARMA GmbH & Co. KG
  • JSR Life Sciences, LLC
  • Lonza Group AG
  • Parexel International Corporation
  • ProBioGen AG
  • Recipharm AB
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific, Inc.
  • Toyobo Co., Ltd.
  • WuXi Biologics Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.15 Billion
Forecasted Market Value ( USD ) by 2032 $ 18.29 Billion
Compound Annual Growth Rate12.1%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Biologics Outsourcing Market - Global Forecast 2026-2032 - Product Image

Biologics Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Biologics Contract Manufacturing Market - Global Forecast 2026-2032 - Product Image

Biologics Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Biologics Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Biologics Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size and Key Geographical Regions - Product Image

Biologics Contract Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size and Key Geographical Regions

  • Report
  • 799 Pages
  • Global
From
Biologics Fill Finish Services Market Report and Forecast 2025-2034 - Product Image

Biologics Fill Finish Services Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.